330 related articles for article (PubMed ID: 27273265)
1. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH
Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
3. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.
Enomoto H; Nakamura H; Liu W; Nishiguchi S
Int J Mol Sci; 2015 Jun; 16(6):14086-97. PubMed ID: 26101867
[TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
Gao W; Chen X; Chi W; Xue M
Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
Enomoto H; Nakamura H; Liu W; Iwata Y; Nishikawa H; Takata R; Yoh K; Hasegawa K; Ishii A; Takashima T; Sakai Y; Aizawa N; Ikeda N; Iijima H; Nishiguchi S
Anticancer Res; 2015 Dec; 35(12):6475-9. PubMed ID: 26637859
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
8. HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.
Xiao Q; Qu K; Wang C; Kong Y; Liu C; Jiang D; Saiyin H; Jia F; Ni C; Chen T; Zhang Y; Zhang P; Qin W; Sun Q; Wang H; Yi Q; Liu J; Huang H; Yu L
Gut; 2013 Mar; 62(3):440-51. PubMed ID: 22490522
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.
Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
Cell Physiol Biochem; 2009; 24(3-4):253-62. PubMed ID: 19710540
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Zhou Y; Zhou N; Fang W; Huo J
Diagn Pathol; 2010 Sep; 5():58. PubMed ID: 20846397
[TBL] [Abstract][Full Text] [Related]
12. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J
J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955
[TBL] [Abstract][Full Text] [Related]
13. Animal and cellular models of hepatocellular carcinoma bone metastasis: establishment and characterisation.
Hou R; Wang YW; Liang HF; Zhang ZG; Liu ZM; Zhang BH; Zhang BX; Chen XP
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1931-43. PubMed ID: 25820528
[TBL] [Abstract][Full Text] [Related]
14. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
15. HDGF-related protein-2 (HRP-2) acts as an oncogene to promote cell growth in hepatocellular carcinoma.
Gao K; Xu C; Jin X; Wumaier R; Ma J; Peng J; Wang Y; Tang Y; Yu L; Zhang P
Biochem Biophys Res Commun; 2015 Mar; 458(4):849-55. PubMed ID: 25689719
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
Tse EY; Ko FC; Tung EK; Chan LK; Lee TK; Ngan ES; Man K; Wong AS; Ng IO; Yam JW
J Pathol; 2012 Mar; 226(4):645-53. PubMed ID: 22072235
[TBL] [Abstract][Full Text] [Related]
18. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
19. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
